GINNA SAYAG: Open Payments
NPI 1336686948 · CRESSKILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 30 payments from 8 companies in 2025. Trend: 2023 $569 · 2024 $297 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $171 |
| PFIZER INC. | 13 | $154 |
| BridgeBio Pharma, Inc. | 1 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| SCPHARMACEUTICALS INC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
Products named: SYMPLICITY G3, Attruby, LEQVIO, ELIQUIS, VYNDAQEL, Kerendia, FUROSCIX, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
